| Literature DB >> 36212495 |
Giorgio Fiore1,2, Giorgia Abete-Fornara1, Arianna Forgione1, Leonardo Tariciotti1,2, Mauro Pluderi1, Stefano Borsa1, Cristina Bana3, Filippo Cogiamanian3, Maurizio Vergari3, Valeria Conte4, Manuela Caroli1, Marco Locatelli1,2, Giulio Andrea Bertani1.
Abstract
Background: Awake surgery (AS) permits intraoperative mapping of cognitive and motor functions, allowing neurosurgeons to tailor the resection according to patient functional boundaries thus preserving long-term patient integrity and maximizing extent of resection. Given the increased risks of the awake scenario, the growing importance of AS in surgical practice favored the debate about patient selection concerning both indication and eligibility criteria. Nonetheless, a systematic investigation is lacking in the literature. Objective: To provide a scoping review of the literature concerning indication and eligibility criteria for AS in patients with gliomas to answer the questions:1) "What are the functions mostly tested during AS protocols?" and 2) "When and why should a patient be excluded from AS?". Materials and methods: Pertinent studies were retrieved from PubMed, PsycArticles and Cochrane Central Register of Controlled Trials (CENTRAL), published until April 2021 according to the PRISMA Statement Extension for Scoping Reviews. The retrieved abstracts were checked for the following features being clearly stated: 1) the population described as being composed of glioma(LGG or HGG) patients; 2) the paper had to declare which cognitive or sensorimotor function was tested, or 2bis)the decisional process of inclusion/exclusion for AS had to be described from at least one of the following perspectives: neurosurgical, neurophysiological, anesthesiologic and psychological/neuropsychological.Entities:
Keywords: awake; awake surgery; brain mapping; brain tumors; eligibility; exclusion criteria; gliomas; indication
Year: 2022 PMID: 36212495 PMCID: PMC9532968 DOI: 10.3389/fonc.2022.951246
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Flowchart of the selection process of this scoping review, according to PRISMA Statement Extension for Scoping Reviews (PRISMA-ScR).
Figure 2(A) The histogram shows the time distribution (by years) of the papers included in the scoping review. (B) The pie chart summarizes distribution of the included papers among the various continents.
Figure 3The histograms show the time distribution (by years) for each function being tested in the included studies.
Figure 4The Well diagram shows the tested functions in the included surgical case series.
Main characteristics of the studies, including relative inclusion and exclusion criteria.
| Authors and year | Number of patients | LGG vs HGG | Kindof Anesthesia | Psychological | Neuropsychological | Neurological and neurosurgical | Aenesthesiological | Other conditions |
|---|---|---|---|---|---|---|---|---|
| Norrelgen F, et al., 2020 ( | 27 | 17 vs 10 | AAA | Severe Aphasia, | Previous Surgery | |||
| Li, T., et al., 2015 ( | 91 | 66 vs 25 | AAA | Disorientation | Cognitive deficit | Neurological deficits | Age: not under 16 years old; not over 60 years old. | |
| Alimohamadi M., et al., 2016 ( | 10 | 7 vs 3 | FA | Psychopatology | Severe Aphasia, Cognitive deficits | Previous Surgery | Obesity, Cardiovascular disease, difficult airways | Age: over 75 years old |
| Saito T., et al., 2016 ( | 82 | 46 vs 36 | FA | Previous Surgery | ||||
| Krieg SM., et al., 2013 ( | 8 | 4 vs 4 | AAA | Severe Aphasia, Cognitive deficits | AS only for lesions infiltrating left pre or post-central gyrus. | |||
| Kuribara T., et al., 2020 ( | 136 | 54 vs 82 | AAA | Severe Aphasia | ||||
| Benyaich Z., et al., 2020 ( | 20 | 18 vs 2 | AAA | Inability to cooperate | KPS of < 70 | ASA ≥ 3 | Age: over 10 years old | |
| Nossek E., et al., 2013 ( | 424 | 80 vs 283 | FA | Inability to cooperate, anxiety | Severe dysphasia | |||
| Bertani G., et al., 2009 ( | 275 | 275 LGG | AAA | Inability to cooperate | Obesity, Cardiovascular disease, difficult airways | Age: over 65 years old | ||
| Huguet L., et al., 2020 ( | 17 | 17 vs 0 | AAA | Inability to cooperate, lack of motivation, alexithymia, recurrent depression, OCD | Outside eloquent areas | |||
| Manchella S., et al., 2011 ( | 16 | 5 vs 11 | AAA | Severe dysphasia | Outside eloquent areas | |||
| Nabavi A., et al., 2008 ( | 34 | NA | FA | Inability to cooperate | Severe Aphasia (< 50% language tests), score MMSE < 23 | Neurological deficits, Outside eloquent areas | ||
| Zigiotto L., et al., 2020 ( | 16 | NA | AAA | Inability to cooperate, anxiety, confusion | Severe Aphasia | Neurological deficits | ||
| Balogun JA., et al., 2019 ( | 1 | 16 HGG | AAA | KPS of < 70 | Obesity, Cardiovascular disease, difficult airways, respiratory diseases | |||
| Pichierri A., et al., 2019 ( | 20 | 11 vs 9 | AC e AAA | Inability to cooperate, anxiety, phobias, altered mental status | Severe dysphasia | Outside eloquent areas | Obesity (BMI > 35), Cardiovascular disease, obstructive sleep apnea, difficult intubation, active acute or chronic cough, uncontrolled seizures | |
| Hulou MM., et al., 2015 ( | 25 | 9 vs 16 | FA | Inability to cooperate, emotional instability, developmental delay | Severe Aphasia | |||
| Giussani C., et al., 2011 ( | 35 | 10 vs 25 | Severe Aphasia | |||||
| Bello L., et al., 2007 ( | 88 | 44 vs 44 | AAA | Severe Aphasia | ||||
| Groshev A., et al., 2017 ( | 44 | 4 vs 40 | FA | Anxiety | Severe intracranial hypertension | Obstructive sleep apnea, history of postanaesthesia nausea and vomiting, bleeding diasthesis, seizures | ||
| Maldaun MV., et al., 2014 ( | 42 | 14 vs 28 | AAA | Outside eloquent areas | ||||
| Lu J., et al., 2013 ( | 30 | 19 vs 11 | FA | Severe Aphasia, score MMSE < 23 | Outside eloquent areas, severe intracranial hypertension | Pacemaker, obstructive sleep apnea | Not pediatric population | |
| Chacko AG., et al., 2013 ( | 67 | 36 vs 31 | AAA | Inability to cooperate | Outside eloquent areas | Age: not under 13 years old | ||
| Klijn E., et al., 2013 ( | 8 | 8 vs 0 | AAA | Outside eloquent areas, suspected LGG | ||||
| Leuthardt EC., et al., 2011 ( | 12 | 4 vs 8 | FA | Obesity, difficult airways, severe diabetes mellitus | ||||
| Sarubbo S., et al., 2011 ( | 12 | 12 LGG | AAA | Inability to cooperate, psychiatric disorders | Severe Aphasia (error rate higher than 25% at naming tests) | |||
| Goebel S., et al., 2010 ( | 25 | 13 vs 12 | FA | Anxiety, depression, severe psychological distress | Severe Aphasia, score MMSE < 23, neglect, impairments in concentration, sustained attention, severely disinhibited, apathic, or disorganized behavior. | Outside eloquent areas | ||
| Sanai N., et al., 2008 ( | 250 | 124 vs 126 | FA | Emotional instability, confusion, decreased level of consciousness | Severe Aphasia, Severe dysphasia | Outside eloquent areas | ||
| Picht T., et al., 2006 ( | 20 | 20 LGG | FA | Inability to cooperate | Severe Aphasia | Obstructive sleep apnea, uncontrolled seizures | ||
| Klimek M., et al., 2004 ( | 1 | 1 HGG | FA | Inability to cooperate, agitation, restlessness | ||||
| Kwinta, B.M., et al., 2021 ( | 25 | 17 vs 8 | AAA | Inability to cooperate | Lovett Scale < 3, Outside eloquent areas | |||
| Coskun, E., 2020 ( | 109 | 17 vs 92 | FA | Depression, psychotic disorders, claustrophobia | Severe Aphasia, Cognitive deficits | |||
| Hejrati, N., et al., 2019 ( | 14 | 5 vs 9 | FA | Inability to cooperate | Severe Aphasia | Obesity, severe gastroesophageal reflux | ||
| Wang, Y.-C., et al., 2019 ( | 41 | 19 vs 22 | AAA | Inability to cooperate | Severe dysphasia | |||
| Sollmann, N., et al., 2018 ( | 60 | 14 vs 46 | AAA | Severe Aphasia | Age: not under 18 years old | |||
| Leal, R.T.M., et al., 2018 ( | 13 | 5 vs 8 | FA | Untreated psychiatric condition, claustrophobia | Cognitive deficits | Outside eloquent areas | Patient refusal | |
| Sitnikov, A.R., et al., 2018 ( | 54 | 35 vs 19 | AAA | Psychoemotional lability | Severe Aphasia | Hemiplegia, Outside eloquent areas | ||
| Leal, R.T.M., et al., 2017 ( | 11 | 4 vs 7 | FA | Untreated psychiatric condition, claustrophobia | > 20 % of errors at preoperative object naming test | MRCMS < 2, Outside eloquent areas | ||
| Bunyaratavej, K., et al., 2016 ( | 27 | 16 vs 11 | FA | Inability to cooperate | > 20 % of errors at preoperative object naming test | Lovett Scale < 3 | ||
| Krieg, S.M., et al., 2014 ( | 30 | 8 vs 22 | FA | Severe Aphasia | Pacemaker | Age: not under 18 years old | ||
| Garavaglia, M.M., et al., 2014 ( | 10 | NA | FA | Inability to cooperate, panic attacks | Neurological deficits, large sizes with midline shift | Obesity, obstructive sleep apnea, difficult airways, severe chronic obstructive pulmonary disease/asthma, severe gastroesophageal reflux | ||
| Deras, P., et al., 2012 ( | 140 | NA | AAA | Severe asthma, severe reduction of mouth opening, partial airway obstruction, severe gastroesophageal reflux | ||||
| Santini, B., et al., 2012 ( | 21 | 8 vs 13 | FA | Psychiatric disorders | > 30% of errors at naming tests and on FAB | KPS of < 70, multifocal lesions | Uncontrolled seizures | Age: not under 18 years old |
| Rughani, A.I., et al., 2011 ( | 18 | 6 vs 12 | AAA | Inability to cooperate | Cognitive deficits | Outside eloquent areas | ||
| Pereira, L.C.M., et al., 2009 ( | 79 | 41 vs 38 | FA | Inability to cooperate, psychologically instability | Severe Aphasia | KPS of < 70, lesions extending to the thalamus, hypothalamus or brainstem, diameter of lesions larger than 10 cm | Systemic diseases, ASA ≥3 | |
| Gupta, D.K., et al., 2007 ( | 24 | 16 vs 8 | FA | Inability to cooperate, developmental delay | Severe Aphasia | Hemiplegia | Age: not under 12 years old |
AAA, asleep-awake-asleep; AC, awake craniotomy; ASA, American Society of Anesthesiologists; BMI, body mass index; FAB, frontal assessment battery; HGG, high grade glioma; LGG, low grade glioma; MMSE, Mini Mental State Examination; MRCMS, Medical Research Council Muscle Strength scale; NA, not available; OCD, Obsessive-compulsive disorder.
Implemented intraoperative tasks and tested function being assessed in relation to specific brain regions.
| Lobe (Regions) |
| Test |
|---|---|---|
|
| ||
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
| ||
|
|
| |
|
| ||
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
| ||
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
| ||
|
|
|
|
|
|
| |
|
|
| |
|
| ||
|
|
| |
AG, angular gyrus; dlPFC, dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; SMG, supramarginal gyrus.
Figure 5Flow-chart of the proposed patient selection process for indication and eligibility to AS suggested by the authors on the basis of this scoping review results.